Clinical trials are getting a massive upgrade thanks to the FDA’s new “RTCT” initiative. Forget waiting months for data review—this shift utilizes AI-enabled data science to beam safety signals and key info to regulators in real-time. It’s a game-changer that forces CROs to trade in old-school reporting for live, transparent dashboards. The future of medical research is moving at the speed of data. #FDA #ClinicalTrials #HealthTech #AI #Innovation - @dansfera